Litcius/Paper detail

Molecular mechanisms of ferroptosis and its role in prostate cancer therapy

Shaokun Wang, Wei Wei, Ning Ma, Yongliang Qu, Qiuju Liu

2022Critical Reviews in Oncology/Hematology40 citationsDOIOpen Access PDF

Abstract

Prostate cancer (PCa) is a highly prevalent disease that affects men's health worldwide and is the second most common malignancy in males. Ferroptosis is a novel form of programmed cell death characterized by iron overload and the accumulation of lipid peroxidation, which differs from the regulated cell death modes of necrosis, apoptosis, and autophagy. Substantial progress has been achieved in researching the occurrence and regulatory mechanisms of ferroptosis, which is closely associated with cancer initiation, progression, and suppression and is expected to become a new breakthrough point in the PCa treatment. This review will summarize the mechanisms involved in PCa, and we detail the molecular mechanisms of ferroptosis and its role in PCa treatment.

Topics & Concepts

Prostate cancerMedicineMalignancyProgrammed cell deathAutophagyCancerApoptosisDiseaseCancer researchProstateGPX4Cause of deathLipid peroxidationBioinformaticsPathologyOxidative stressInternal medicineBiologyGeneticsGlutathione peroxidaseCatalaseFerroptosis and cancer prognosisCancer, Lipids, and MetabolismCancer-related molecular mechanisms research
Molecular mechanisms of ferroptosis and its role in prostate cancer therapy | Litcius